Surveyor Capital
Investor profile
Venture capital
Deals
4
distinct rounds
Companies
4
backed
Active span
2021–2023
3 yrs
Total round €
€516M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- TCG X2
- Vivo Capital2
- AbbVie Ventures1
- Abingworth LLP1
- Aisling Capital1
- Armistice Capital1
- Cowen Healthcare Investments1
- Driehaus Capital Management1
- Droia Ventures1
- Eventide Asset Management1
- Forbion's Growth Opportunities Fund1
- Frazier Life Sciences1
- GIMV1
- INKEF Capital1
- Laurion Capital Management1
- Logos Capital1
- Marshall Wace1
- Mission BioCapital1
- MRL Ventures Fund1
- Nextech Invest1
- Omega Funds1
- OrbiMed1
- Paradigm BioCapital Advisors1
- Pfizer Ventures1
- PFM Health Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Compass Pathways | UK | 1 | €262M |
| Vectivbio | Switzerland | 1 | €128M |
| Ambagon Therapeutics | Netherlands | 1 | €75M |
| Anjarium Biosciences | Switzerland | 1 | €51M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Compass Pathways | Other | €262M | 2023-08 |
| Vectivbio | Other | €128M | 2022-10 |
| Ambagon Therapeutics | Series A | €75M | 2022-01 |
| Anjarium Biosciences | Series A | €51M | 2021-09 |